Background and Purpose-Endovascular therapy of acute ischemic stroke has been shown to be beneficial for selected patients. The purpose of this study is to determine predictors of outcome in a large cohort of patients treated with intra-arterial thrombolysis, mechanical revascularization techniques, or both. Methods-We prospectively acquired data for 623 patients with acute cerebral infarcts in the carotid artery territory who received endovascular treatment at a single center. Logistic regression analysis was performed to determine predictors of outcome. Results-Median National Institutes of Health Stroke Scale (NIHSS) at admission was 15. Partial or complete recanalization was achieved in 70.3% of patients; it was independently associated with hypercholesterolemia (Pϭ0.02), absence of coronary artery disease (Pϭ0.023), and more proximal occlusion site (PϽ0.0001). After 3 months, 80.5% of patients had survived, and 48.9% of patients reached favorable outcome (modified Rankin scale score 0 -2). Good collaterals (PϽ0.0001), recanalization (Pϭ0.023), hypercholesterolemia (Pϭ0.03), lower NIHSS at admission (Pϭ0.001), and younger age (PϽ0.0001) were independent predictors for survival. More peripheral occlusion site (PϽ0.0001), recanalization (PϽ0.0001), hypercholesterolemia (Pϭ0.002), good collaterals (Pϭ0.002), lower NIHSS (PϽ0.0001), younger age (PϽ0.0001), absence of diabetes (Pϭ0.002), and no previous antithrombotic therapy (Pϭ0.036) predicted favorable outcome. Time to treatment was only a predictor of outcome, when collaterals were excluded from the model. Symptomatic intracerebral hemorrhage occurred in 5.5% and was independently predicted by poor collaterals (Pϭ0.004). Conclusions-Several independent predictors for outcome and complications were identified. Unlike in intravenous thrombolysis trials, time to treatment was a predictor of outcome only when collaterals were excluded from the model, indicating the important role of collaterals for the time window. (Stroke. 2012;43:00-00.)
I n 1981, Zeumer et al performed a successful local intra-arterial thrombolysis (IAT) in a patient with basilar artery occlusion. 1 This kindled interest in IAT, and randomized trials showed a benefit of IAT for acute ischemic stroke with middle cerebral artery occlusion. [2] [3] [4] Various case series showed that IAT can be safely and efficaciously performed in clinical practice. 2, 4, 5 In selected stroke patients, ie, in patients with hyperdense middle cerebral artery on computed tomography, IAT may be more effective than is intravenous thrombolysis (IVT) with recombinant tissue-type plasminogen activator. 6 Today, endovascular stroke therapy uses both drugs, mostly recombinant tissue-type plasminogen activator or urokinase, and mechanical means for thrombus dissolution and removal to enhance the chances of vessel recanalization. [7] [8] [9] [10] In the decision process for treatment and patient selection for endovascular therapy, clinical and radiological factors that are linked to outcome are needed, and these can only be gained from randomized trials or from large, nonrandomized patient registries. The aim of this study was to identify predictors of outcome and bleeding complications in a large series of 623 patients with acute ischemic stroke in the carotid, middle, or anterior cerebral artery territories who were treated with endovascular therapy.
Patients and Methods

Patients
From May 1992 to September 2010, we treated 741 patients with endovascular therapy, 623 patients (84%) with occlusions in the anterior (carotid, middle, or anterior cerebral arteries) and 118 patients (16%) in the posterior circulation (vertebral, basilar, and posterior cerebral arteries). Some aspects of these patients have been reported previously. 6, 11, 12 A neurologist examined all patients immediately after admission to the emergency room, and the neurological deficit was scored using the National Institutes of Health Stroke Scale (NIHSS). Demographic and clinical data were recorded (age, sex, premedication, time of symptom onset, coronary artery disease, atrial fibrillation, hypertension, diabetes, current smoking, hypercholesterolemia according to history or current lipid values, history of transient ischemic attack or ischemic stroke, and family history of transient ischemic attack and stroke). Afterward, patients underwent computed tomography (CT) or magnetic resonance imaging (MRI). IAT was performed with the consent of the patient or his family immediately after CT or MRI if: diagnosis of ischemic stroke was established, baseline NIHSS score was Ն4 or isolated aphasia or hemianopia was present, hemorrhage on cranial CT or MRI was not found, vessel occlusion correlated with the neurological deficit, symptom duration was not longer than 24 hours, and no individual clinical or premorbid conditions or laboratory findings advised against thrombolysis. On MRI, a mismatch indicating viable tissue was considered to be present when the area with reduced perfusion on perfusion-weighted imaging was larger than was the area with restricted diffusion on diffusion-weighted imaging. Digital subtraction angiography was performed via a transfemoral approach using a biplane, high-resolution angiography system. In general, 4-vessel cerebral angiography was performed. Only in a minority of patients with tortuous or severely atherosclerotic extracranial vessels, angiography was limited to the vessel that was presumably occluded according to clinical findings and noninvasive imaging. The site of the artery occlusion was categorized as follows: proximal and distal internal carotid artery, carotid-T, M1/M2/M3-4 segments of the middle cerebral artery, and A1/A2 segments of the anterior cerebral artery. Collaterals were classified as none; poor, if minimal leptomeningeal anastomoses were visualized and no or minimal filling of the occluded vessel territory was seen; and good, if leptomeningeal anastomoses filled the occluded vessel territory more than half. 11 The interventional neuroradiologists decided on the use of urokinase, mechanical intervention, or both as recanalization techniques. The technique of mechanical thrombectomy and thrombus fragmentation has evolved during the 18 years of data acquisition. Initially, mechanical manipulation of the clot with the guide wire was used to fragmentize it in conjunction with intra-arterial thrombolysis, and later also thrombaspiration. In the meantime, the thrombectomy approaches with or without additional application of thrombolytic drugs (eg, stent-retrievers) are increasingly applied. At the end of angiography, recanalization was classified according to thrombolysis in myocardial infarction (TIMI) grades: 0ϭno recanalization, 1ϭminimal recanalization, 2ϭpartial recanalization, and 3ϭcomplete recanalization.
A CT or MRI scan was obtained 24 to 72 hours after treatment or in any case of clinical deterioration. Symptomatic (sICH) and asymptomatic (aICH) intracranial hemorrhages were graded according to the Prolyse in Acute Cerebral Thromboembolism (PROACT) II study. 13 The etiology of stroke was classified according to the Trial of Org 10172 (TOAST) criteria, using ancillary investigations as necessary; secondary preventive treatment was given according to European guidelines. 14, 15 Clinical outcome was assessed 3 months after the stroke using the modified Rankin scale (mRS).
The study was performed according to the ethical guidelines of the Canton of Bern and with corresponding permission.
Statistical Analysis
Statistical analysis was performed using SPSS 18 (SPSS Inc.). Categorical variables were compared with 2 and Fisher exact test as appropriate and continuous variables with Mann-Whitney U test. Outcome was dichotomized into favorable (mRS 0 -2) and poor clinical outcome (mRS 3-6); recanalization as seen on digital subtraction angiography was categorized into good (TIMI grades 2-3) and poor recanalization (TIMI grades 0 -1). NIHSS after 24 hours was dichotomized into clinical improvement and unchanged or worsened neurological deficits compared with baseline NIHSS. Forward stepwise logistic regression including all variables with PϽ0.2 in univariate analysis (age, sex, time to thrombolysis, NIHSS score on admission, atrial fibrillation, vessel dissection, diabetes, hypertension, hypercholesterolemia, coronary artery disease, previous stroke or transient ischemic attack, smoking, family history of stroke, occlusion type, degree of collaterals, recanalization after IAT, dose of urokinase, previous treatment with any antithrombotics [including vitamin K antagonists]) was used to determine the predictors of clinical outcome, survival, recanalization, and bleeding complications. A probability value of Ͻ0.05 was considered significant.
Results
Baseline characteristics of the 623 treated patients are given in Table 1 . Initial brain imaging was performed with CT in 339 patients, MRI in 221 patients, and both in 57 patients. In 6 patients, vessel occlusion occurred during digital subtraction angiography, and they had no brain imaging before endovascular treatment. A hyperdense artery sign on CT was noted in 198 patients (51.6%). In 245 patients, the MRI protocol included both diffusion-and perfusion-weighted images, and 225 of them (91.8%) showed a diffusion-perfusion mismatch. The occlusion site as seen on digital subtraction angiography was the internal carotid artery in 103 patients (16.5%), the carotid-T in 75 patients (12.0%), the M1 segment of the middle cerebral artery (MCA) in 278 patients (44.6%), the M2 segment in 105 patients (16.9%), the M3/4 segment in 54 patients (8.7%), and the anterior cerebral artery in 8 patients (1.3%). Two or more vessels were occluded in 122 patients (19.6%): internal carotid artery and at least 1 intracranial vessel in 88 patients or 2 or more intracranial vessel occlusions in 34 patients. The most frequent occlusion combinations were proximal internal carotid artery and carotid-T in 24 patients, proximal internal carotid artery and MCA in 59 patients, and MCA occlusion combined with anterior cerebral artery occlusion in 23 patients. The median baseline NIHSS score was 15. Treatment, outcome, recanalization, and complications are given in Figure 1 . Table 3 shows the predictors of recanalization, survival, functional outcome, and bleeding after multiregression analysis. TIMI 2 to 3 recanalization was independently associated with hypercholesterolemia, absence of coronary artery disease, and site of the occluded vessel. Proximal occlusions showed better recanalization rates than did distal occlusions.
Survival was predicted by good collaterals, successful recanalization, hypercholesterolemia, NIHSS on admission, and younger age. In addition, the localization of the occluded vessel independently predicted survival.
Favorable outcome at 3 months was independently predicted by vessel recanalization, hypercholesterolemia, good collaterals, lower NIHSS at admission, younger age, absence of diabetes, and no previous antithrombotic therapy. In addition, the location of the occluded vessel independently predicted outcome. Carotid-T-occlusions were associated with the worst outcome ( Figure 1 ). Successful recanalization (TIMI 2-3), hypercholesterolemia, and good collaterals turned out as the strongest predictors of favorable (all OR, Ͼ1.5) and diabetes mellitus of adverse outcome (OR, 0.385). When collaterals were excluded from the model, time to treatment was another predictor for favorable outcome (Pϭ0.017; OR, 0.997), but not for survival (Pϭ0.087).
Poor collaterals were the only independent predictors of sICH and higher NIHSS and atrial fibrillation of aICH.
Discussion
Intra-arterial thrombolysis has been proven as an effective therapy for selected patients with acute ischemic stroke, both in randomized trials and in uncontrolled series that were analyzed with multivariate logistic regression. [2] [3] [4] 7 However, unlike the large randomized trials with IVT, randomized trials with IAT included smaller numbers of patients, and their positive results are less robust. Therefore, results of outcome, knowledge of treatment complications, and their predictors after IAT get special attention. In this study, we analyzed a large cohort of 623 consecutive patients with anterior circulation stroke who had been treated with IAT in our stroke unit. We did not include posterior circulation strokes in this analysis, because posterior circulation strokes differ from anterior circulation strokes.
Four hundred ninety-four of the 623 patients (80.5%) survived and 300 patients (48.9%) had a favorable outcome 3 months after stroke. These rates are similar or even better than the outcome in trials like the PROACT II trial (mRS 0 -2, 40%), 3 the Mechanical Embolus Removal in Cerebral Ischemia (MERCI) and Multi MERCI Trials (mRS 0 -2, 36% and 39%), 7, 16 or the Middle Cerebral Artery Embolism Local Fibrinolytic Intervention (MELT) trial (mRS 0 -2, 49%). 4 Proximal, and thus, larger occlusions, such as internal carotid artery and carotid-T-occlusions, showed less-favorable outcomes (mRS 0 -2, 37.0% and 13.3%, respectively) than did more peripheral occlusions in the MCA territory (mRS 0 -2 M1: 52.2%; M2, 64.1%; and M3/4, 74.1%). Overall, TIMI 2 to 3 recanalization as seen on digital subtraction angiography was achieved in 70.3% of our patients. Reported recanalization rates in the anterior circulation range from 46% to 71.4% for IAT and 26% to 60% for IVT. 3, 17, 18 The recanalization rate in this series improved during the study time. It rose from 66.7% from 1992 to 1996 to 76.6% from 2007 to 2011, most likely because of the advent of better mechanical recanalization means. As illustrated in Figure 1 , more proximal occlusions were associated with better recanalization, probably because of more mechanical interventional techniques in proximal occlusions.
Of 266 patients with next-day NIHSS follow-up, 62.4% improved, and improvement was independently predicted by better recanalization, absence of sICH, and younger age. A next-day NIHSS improvement was associated with better outcome and survival at 3 months.
In multivariate analysis, good collaterals, successful recanalization, and hypercholesterolemia were found to be the strongest predictors for survival, whereas lower NIHSS on admission and younger age predicted survival only weakly. In addition, the site of the vessel occlusion independently predicted survival.
Favorable outcome at 3 months was predicted by better recanalization, hypercholesterolemia, good collaterals, lower NIHSS at admission, lower age, absence of diabetes, and no previous antithrombotic therapy. In addition, the location of the occluded vessel within the anterior circulation independently predicted outcome, with carotid-T-occlusions being associated with the worst outcome; this is most likely because the T-occlusion cuts off the most important channel for collateral blood supply, the circle of Willis (Figure 1 ). Good recanalization, hypercholesterolemia, collaterals, and absence of diabetes mellitus were the strongest predictors for favorable outcome.
Other studies reported age, diabetes, NIHSS on admission, and occlusion type as independent outcome predictors. Also, good recanalization 16, 17, 19, 20 and good collaterals 21 were identified as predictors of favorable outcome. In our series, previous antithrombotic therapy was found to be an additional predictor, namely a predictor of unfavorable outcome. However, previous antithrombotic therapy might be a confounding variable because of comorbidities for which these medications are used.
The association of hypercholesterolemia with better outcome and survival is somehow unexpected, given that first-ever and recurrent ischemic strokes occur more frequently with rising cholesterol levels. The association of hypercholesterolemia with better outcome and survival remained consistent in a subgroup analysis after exclusion of patients with previous statin treatment (Supplemental Table, http://stroke.ahajournals.org). Other groups found similar associations for stroke and acute coronary artery disease. 22, 23 An explanation might be an antioxidative effect of cholesterol that contributes to increased hypoxic tolerance of neurons. 22 Another possible explanation is a confounding effect of statin therapy, which was given to all patients diagnosed with hypercholesterolemia. However, studies before the statin era showed longevity and lesser risk of infection to be associated with higher cholesterol in the very old, indicating a protective effect of cholesterol once persons become frail and sick. 24 A similar protective effect might also explain the better outcome and survival rates in stroke patients with higher cholesterol levels.
Time from symptom onset to treatment did not predict outcome or complications. This is somehow surprising, given that shorter time to treatment was associated with better odds for outcome in IVT trials. 25 However, when collaterals were excluded from our multivariate model, shorter time to treatment turned out to be a predictor of favorable outcome. Thus, collaterals, which were not assessed in IVT trials, seem to be a more important factor for outcome in endovascular therapy than is time to treatment. This apparent discrepancy can be explained by the type of patients treated. In our series, unlike in IVT trials, the majority of patients had internal carotid artery and proximal MCA occlusions, which have more anatomic collateral channels than do peripheral occlusions. In addition, a study of thrombus lengths showed the importance of the size of the occluded vessel and thrombus. 26 IVT has nearly no potential to recanalize occluded vessels if thrombus length exceeds 8 mm, whereas thrombus length plays a minor role for mechanical recanalization.
Reported rates of sICH in the literature range from 9.8% to 15.4% 2, 7 in IAT and 2.4% to 19.8% 25, 27 in IVT. In our patients, we observed sICH in 34/622 patients (5.5%) and aICH in 110/622 patients (17.7%). These relatively low rates of sICH may be associated with the use of urokinase instead of other thrombolytics, only mechanical means in some patients, or other factors, such as avoidance of heparin or heparinoids for at least 24 hours after thrombolysis. Aspirin, however, was given routinely before or during the endovascular procedure. Worse collaterals were the only independent predictor for sICH ( Figure  2 ), which was also found by Christoforidis et al. 28 Atrial fibrillation and higher NIHSS on admission independently predicted aICH. The influence of NIHSS might be explained by the larger infarct size. Increased intrinsic fibrinolytic activity in response to a prothrombotic state in atrial fibrillation might represent another mechanism responsible for the association of aICH and atrial fibrillation. 29 A major limitation of our study is the selection of our patients. Our patients are highly selected given that we tend to treat patients with branch occlusions with IVT and patients with proximal occlusions with endovascular therapy. Patients who were treated with endovascular therapy in our center differ from 
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patients included in IVT trials. The median NIHSS score was 15 (ie, higher than in the IVT trials), the average time to treatment was almost 4.5 hours, and more than 90% of our patients had occlusions of large proximal vessels (internal carotid artery, M1, M2). In addition, this is a nonblinded, single-center study with individualized treatment decisions. Also, endovascular treatment procedures changed over time. Conversely, this limitation of selection bias can also be interpreted positively: our results indicate that a comprehensive stroke center needs both treatment modalities: endovascular techniques for more proximal vessel occlusions, and IVT for more peripheral vessel occlusions, that cause acute stroke.
Conclusions
Several independent predictors for outcome and complications were identified in this large series of stroke patients treated with endovascular therapy. Unlike in IVT trials, time to treatment was a predictor of outcome only when collaterals were excluded from the model. Therefore, collaterals play an important role for the longer time window in which endovascular therapy can be applied compared with IVT. 
